Science AdvancesMicrobiologyPeer-reviewed journal article
The genetic landscape of antibiotic sensitivity in Staphylococcus aureus
Li WaniD, Menghan LiuiD, Panos OikonomouiD, Sydney B. BlattmaniD, Mirela BerisaiD, Falguni PauliD, Julia Hettleman, Joseph GonzaleziD, Qiaoyu HuiD, Howe CheniD, Saeed TavazoieiD, Wenyan JiangiD
Abstract
A comprehensive genetic landscape of antibiotic sensitivity in Staphylococcus aureus is lacking. Using ultra-dense CRISPR-interference libraries, we systematically quantified global gene fitness across ten antibiotics and uncovered hundreds of significant antibiotic-gene interactions. Essential genes dominated these interactions, a finding not revealed by transposon-based studies. Processes most vulnerable to transcriptional repression under antibiotic conditions included cell wall synthesis/cell division (CC), DNA replication/DNA recombination (DD), coenzyme A biosynthesis, and riboflavin metabolism. Network and genetic analyses further revealed novel synergistic genetic interactions (GIs) within these processes, including an extensive CC-DD subnetwork. Only a subset of CC-DD synergies was dependent on the cell division inhibitor SosA. Informed by these GIs, we identified multiple drug-drug combinations with potent synergistic activity against multidrug-resistant S. aureus. Our detailed profiling of drug-gene, gene-gene, and drug-drug interactions reveals novel functional relationships among essential genes and defines a vulnerability landscape to guide new drug target discovery and effective combination therapies.
- organism: human
- assay: CRISPR screen
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 5
- FWCI
- 14.98
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Strain-resolved CRISPRi-Seq reveals conserved antibiotic vulnerabilities in Staphylococcus aureus
Maria-Vittoria Mazzuoli, Jessica Burnier, … Jan‐Willem Veening·bioRxiv·Oct 13, 2025
- High-throughput profiling of drug interactions in Gram-positive bacteria
- Genome-wide CRISPRi screens reveal the essentialome and determinants for susceptibility to dalbavancin in Staphylococcus aureus
X. Liu, V. de Bakker, … M. Kjos·bioRxiv·Aug 30, 2023
- A duplexed CRISPRi-based approach to predict synergistic antibiotic targets in Escherichia coli.
Xianyi Xiong, Hannah Furseth, … William R. Harcombe·bioRxiv·May 15, 2024
- Synergistic CRISPR-Cas Antimicrobials through Essential and Defensive Gene Cotargeting in Staphylococcus aureus
David S. Dooley, Cong T. Trinh·bioRxiv·Jun 27, 2026
- Systematic mapping of antibiotic cross-resistance and collateral sensitivity with chemical genetics
Nazgul Sakenova, Elisabetta Cacace, … Athanasios Typas·Nature MicrobiologyPeer-reviewed·Dec 2, 2024